A descriptive evaluation of unfractionated heparin use during pregnancy

By Clark Nathan   Delate Thomas   Witt Daniel   Parker Suzanne   McDuffie Robert  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 267-273

Springer Publishing Company

Access to resources Recommend Favorite

Electronic Medical Records in a Sub-Specialty Practice: One Asthma Center's Experience

By Tolomeo Concettina   Shiffman Richard   Bazzy-Asaad Alia  

Journal of Asthma, Vol. 45, Iss. 9, 2008-11 ,pp. : 849-851

Informa Healthcare

Access to resources Recommend Favorite

Anti-thrombotic Efficacies of Enoxaparin, Dalteparin, and Unfractionated Heparin in Venous Thrombo-embolism

By Morris T.A.   Marsh J.J.   Konopka R.   Pedersen C.A.   Chiles P.G.  

Thrombosis Research, Vol. 100, Iss. 3, 2000-11 ,pp. : 185-194

Elsevier

Access to resources Recommend Favorite

Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges

By van den Besselaar A.M.H.P.   Sturk A.   Reijnierse G.L.A.  

Thrombosis Research, Vol. 107, Iss. 5, 2002-09 ,pp. : 235-240

Elsevier

Access to resources Recommend Favorite

Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis

By Kearon C.   Harrison L.   Crowther M.   Ginsberg J.S.  

Thrombosis Research, Vol. 97, Iss. 6, 2000-03 ,pp. : 395-403

Elsevier

Access to resources Recommend Favorite